Keywords: skye, zileuton, deal, critical, thera, uk, skyepharma
Skye's zileuton deal with Critical Thera
Article | 30 November 2003
The UK's SkyePharma has entered into an agreement with privately-held US firm Critical Therapeutics to develop a controlled-release formulation of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
